News in brief: Immunotherapy falls short in real world OS results; Methotrexate mutes vaccine response; Shared care trialled for prostate cancer patients

Real world immunotherapy outcomes don’t match RCT results Older patients with advanced non–small cell lung cancer treated with immunotherapy show lower survival rates in real world settings compared to those reported in key clinical trials, a study of US Medicare patients shows. A cohort study that included 19,529 patients who started first systemic therapy for ...

Already a member?

Login to keep reading.

© 2022 the limbic